Relapsed And Or Refractory B Cell Lymphoma clinical trials

Explore recruiting relapsed and or refractory b cell lymphoma clinical trials.

Recruiting relapsed and or refractory b cell lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed And Or Refractory B Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The goal of this clinical study is to learn more about the safety and dosing of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma.

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Relapsed And Or Refractory B Cell Lymphoma trials by city

Relapsed And Or Refractory B Cell Lymphoma in Toronto Relapsed And Or Refractory B Cell Lymphoma in Vancouver Relapsed And Or Refractory B Cell Lymphoma in Montreal Relapsed And Or Refractory B Cell Lymphoma in Calgary Relapsed And Or Refractory B Cell Lymphoma in Edmonton Relapsed And Or Refractory B Cell Lymphoma in Ottawa Relapsed And Or Refractory B Cell Lymphoma in Winnipeg Relapsed And Or Refractory B Cell Lymphoma in Quebec City Relapsed And Or Refractory B Cell Lymphoma in Hamilton Relapsed And Or Refractory B Cell Lymphoma in Kitchener Relapsed And Or Refractory B Cell Lymphoma in London Relapsed And Or Refractory B Cell Lymphoma in Halifax Relapsed And Or Refractory B Cell Lymphoma in New York Relapsed And Or Refractory B Cell Lymphoma in Los Angeles Relapsed And Or Refractory B Cell Lymphoma in Chicago Relapsed And Or Refractory B Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease